NClip

Documentation at Reassessment sa Medication Administration

5 min na pagbabasa

Documentation at Reassessment sa Medication Administration

Mahahalagang Punto

  • Pinatutunayan ng dokumentasyon pagkatapos ng medication administration ang right documentation at right response.
  • Dapat napapanahon, tumpak, at approved terminology/abbreviations lamang ang charting.
  • Bahagi ng legal medical record ang medication documentation at dapat kumpleto, maaasahan, at defensible.
  • Nangangailangan ang PRN medication effects ng reassessment batay sa route-specific onset windows.
  • Para sa IV push administration, isama ang route/rate, flush solution details, IV site location, at kaugnay na pre/post assessment findings.
  • Dapat makuha sa IV push charting ang parehong indication at measurable response data (halimbawa urine output, lung sounds, edema trend, pain-score change).
  • Dapat makuha sa MAR/eMAR entries ang medication, dose, route, time, indication/instructions, at clinically relevant response data.
  • Para sa enteral tube medication administration, i-chart ang flush volumes sa I&O, route-specific tube details, at feed/suction hold-resume actions ayon sa policy.
  • Nagdadagdag ng safety layers ang eMAR alerts/prompts pero hindi nito pinapalitan ang independent nursing clinical judgment.
  • Dapat gumamit ng four-digit military notation (24-hour clock) sa time documentation para maiwasan ang AM/PM conversion errors.

Equipment

  • MAR at patient medical record access
  • eMAR access at downtime paper-MAR workflow ayon sa facility policy
  • Approved abbreviation/reference guide ayon sa facility policy
  • Post-medication assessment tools (pain scale, reaction check, vital signs)
  • Provider-notification workflow para sa adverse events

Procedure Steps

  1. Idokumento agad ang medication administration pagkatapos maibigay ang dose.
  2. Huwag mag-chart ng medication administration bago aktwal na maibigay ang gamot.
  3. Itala ang mahahalagang detalye: medication name, dose, route, four-digit military time (24-hour clock), administration site kung naaangkop, at ordered/administration attribution fields na kailangan sa chart.
  4. Sa eMAR downtime o paper-MAR use, i-transcribe nang tama ang bawat active order (medication, dose, route, frequency, prescriber, order date/time, at scheduled administration times) gamit ang facility MAR template.
  5. Para sa paper MAR administration entries, i-initial ang eksaktong date/time box at tiyaking maiuugnay ang initials sa printed name/signature sa MAR identifier section.
  6. Approved abbreviations lamang ang gamitin at iwasan ang unsafe symbols o ambiguous shorthand.
  7. Para sa PRN medications, i-chart ang indication, effectiveness, at anumang reaction findings.
  8. Para sa IV push workflows, idokumento ang administration rate, flush solution type/volume/rate, at IV site location/patency findings na kaugnay ng dose event.
  9. Para sa enteral-tube medication workflows, idokumento ang tube route, pre-/between-/post-med flush volumes, feeding o suction hold/resume timing, at total flush volume sa intake/output records ayon sa policy.
  10. Repasuhin ang eMAR prompts/alerts (halimbawa allergy, contraindication, discontinued order, o too-soon administration warning) at i-reconcile ito sa bedside assessment bago final sign-off.
  11. Isagawa ang post-administration reassessment ayon sa route/onset guidance.
  12. Para sa oral medications, karaniwang i-reassess ang response sa loob ng humigit-kumulang 30 hanggang 60 minuto maliban kung may medication-specific policy na iba.
  13. Para sa IV medications, mas maagang i-reassess ang response (karaniwang humigit-kumulang 5 hanggang 15 minuto) ayon sa medication onset at policy.
  14. Para sa pain workflows, karaniwang reassessment targets ay humigit-kumulang 30 hanggang 60 minuto pagkatapos ng oral analgesics at humigit-kumulang 10 hanggang 15 minuto pagkatapos ng IV analgesics.
  15. Idokumento ang objective response findings at patient-reported outcomes.
  16. Para sa respiratory medications, malinaw na ihambing ang pre/post respiratory findings (respiratory rate, SpO2, lung sounds, work of breathing, at dyspnea trend) at agad mag-escalate kung hindi bumubuti o lumalala ang sintomas.
  17. Kung may missed o refused dose sa paper MAR, sundin ang facility notation standards at itala ang dahilan kasama ang follow-up assessment timing sa designated narrative area.
  18. Kung may adverse reaction, idokumento ang event details sa MAR kasama ang required progress note content, provider notification, at follow-up orders.
  19. Markahan nang malinaw ang non-administration dates para sa pre-order o post-discontinuation periods, at lagyan ng anotasyon ang order changes/discontinuation kasama ang date at initials ayon sa facility MAR convention.
  20. Itama agad ang documentation errors kapag natukoy: gamitin ang electronic edit function para sa eMAR entries at sundin ang paper-chart correction rules kapag downtime forms ang gamit.
  21. Sa paper MAR corrections, gumuhit ng iisang linya sa error at maglagay ng date/initials; huwag magbura, gumamit ng correction fluid, o takpan ang original entry gamit ang maraming strike lines.
  22. Isama ang narrative response details na nagpapahintulot ng clinical trend comparison sa handoff at reassessment.
  23. Kumpirmahing sinusuportahan ng charting ang continuity, safety, at legal record standards.

Karaniwang Pagkakamali

  • Naantalang charting → omission, duplicate-dose, at continuity risk.
  • Paggamit ng unapproved symbols/abbreviations → misinterpretation at medication error risk.
  • Nawawalang PRN indication at reassessment → hindi masusuri ang treatment effectiveness.
  • Nawawalang IV push rate/flush details o site-specific findings → hindi kumpletong dose-accountability at troubleshooting trail.
  • Nawawalang enteral flush I&O totals o feed/suction hold-resume charting → hindi kumpletong medication-delivery traceability.
  • Hindi kumpletong adverse-event documentation → naantalang escalation at legal vulnerability.
  • Nawawalang paper-MAR notation para sa missed/refused doses → hindi malinaw na accountability at handoff gaps.
  • Hindi pagpansin sa eMAR alerts o sobrang pagdepende sa prompts nang walang bedside judgment → maiiwasang administration/documentation harm.
  • Paulit-ulit na chart corrections dahil sa distraction-prone workflow → tumataas na panganib ng secondary documentation errors.

Graph View

Mga Backlink